🔗 Share this article Patients Stopping Slimming Jabs Put On Weight Four Times Faster Compared to Those on Conventional Diets Obesity treatment involves long-term strategies. New research suggests that individuals who stop using popular slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans. Research printed in a leading health publication demonstrates that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month once they quit. "People purchasing such medications must be aware of the risk of rapid rebound weight gain when the medication ends," cautioned lead investigator Dr. Susan Jebb. That rate of recovery suggests a reversion to starting weight within about 18 months. Comparing Treatments The research, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills. Scientists note that people who lose weight through diet and exercise generally see a slower creep back—approximately 0.1 kg a month—after stopping. The Reason for the Rapid Regain Experts believe the way of the injections explains the amplified regain. GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate hunger. "Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist. "Withdrawal of this medication leads to hunger is unsuppressed, making binge eating far more likely." An Ongoing Disease? Medical guidelines advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications. Many experts say that, considering the likelihood of weight regain, the therapy is often long-term. This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like high blood pressure. User Testimonies Individuals who have stopped the jabs describe a intense resurgence of cravings. "It was like a switch flipping and I was suddenly extremely hungry," described one woman. This challenge is exacerbated if patients have not established lasting lifestyle or habit modifications during treatment. Significant Adoption Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial. Adoption is higher among women than males. The 40s and 50s demographic shows the highest usage rates. A large proportion access the medications through private healthcare rather than the NHS. Finally, researchers caution that while the jabs are powerful agents for weight loss, they are not a magic fix and lasting health benefits likely depends on combined behavioural changes.
Obesity treatment involves long-term strategies. New research suggests that individuals who stop using popular slimming jabs like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans. Research printed in a leading health publication demonstrates that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month once they quit. "People purchasing such medications must be aware of the risk of rapid rebound weight gain when the medication ends," cautioned lead investigator Dr. Susan Jebb. That rate of recovery suggests a reversion to starting weight within about 18 months. Comparing Treatments The research, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills. Scientists note that people who lose weight through diet and exercise generally see a slower creep back—approximately 0.1 kg a month—after stopping. The Reason for the Rapid Regain Experts believe the way of the injections explains the amplified regain. GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate hunger. "Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist. "Withdrawal of this medication leads to hunger is unsuppressed, making binge eating far more likely." An Ongoing Disease? Medical guidelines advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications. Many experts say that, considering the likelihood of weight regain, the therapy is often long-term. This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like high blood pressure. User Testimonies Individuals who have stopped the jabs describe a intense resurgence of cravings. "It was like a switch flipping and I was suddenly extremely hungry," described one woman. This challenge is exacerbated if patients have not established lasting lifestyle or habit modifications during treatment. Significant Adoption Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial. Adoption is higher among women than males. The 40s and 50s demographic shows the highest usage rates. A large proportion access the medications through private healthcare rather than the NHS. Finally, researchers caution that while the jabs are powerful agents for weight loss, they are not a magic fix and lasting health benefits likely depends on combined behavioural changes.